Provention Bio, Inc. Purchase Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement, dated October 4, 2022, between Provention Bio, Inc. and Aventis Inc
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
DE
2023
Amendment No. 1 to the Asset Purchase Agreement between Provention Bio, Inc. and MacroGenics, Inc., dated November 30, 2022 (, Exhibit 10.29)
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
DE
2023
Form of Purchase Agreement, dated as of July 7, 2022, among Provention Bio, Inc. and each Purchaser party thereto
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
NY
2022
Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
DE
2018
Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
DE
2018
Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
DE
2018
Form of Securities Purchase Agreement between Provention and investors for an offering completed on April 25, 2017
Purchase Agreements
Provention Bio, Inc.
Pharmaceuticals
DE
2018